Company intelligence / Profile preview

Labiofam

Havana, La Habana, Cuba
Ownership
Private
Employees
~5000
Development stage
Other
01

Overview

Labiofam is a prominent Cuban state-owned biotechnology and pharmaceutical conglomerate specializing in the development and production of vaccines, medicines, and biological products for both human and veterinary use. The company is internationally recognized for its research into natural products, most notably Vidatox, a homeopathic cancer treatment derived from the venom of the blue scorpion (Rhopalurus junceus). Beyond human health, Labiofam is a global leader in vector control and agricultural biotechnology, producing bio-pesticides and bio-fertilizers used to combat diseases like malaria and dengue. The organization operates multiple manufacturing plants across Cuba and has established production facilities in several countries in Africa and Asia to support regional health initiatives. Labiofam's business model emphasizes South-South cooperation, exporting its diverse portfolio of over 200 products to more than 60 countries.

Therapeutic areas
HematologyOtherInfectious DiseasesPulmonologyOncology
Modalities
Small moleculeBiologicVaccinePeptidesNatural productsMicrobial therapy
Industry
Biotech
02

Partnerships

Government of TanzaniaGovernment of EthiopiaGovernment of Vietnam

Beyond the preview

Go deeper on Labiofam.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labiofam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call